AU1579700A - Cytokine combination therapy - Google Patents

Cytokine combination therapy

Info

Publication number
AU1579700A
AU1579700A AU15797/00A AU1579700A AU1579700A AU 1579700 A AU1579700 A AU 1579700A AU 15797/00 A AU15797/00 A AU 15797/00A AU 1579700 A AU1579700 A AU 1579700A AU 1579700 A AU1579700 A AU 1579700A
Authority
AU
Australia
Prior art keywords
combination therapy
cytokine combination
cytokine
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15797/00A
Inventor
Patrick T. Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbor Biosciences Inc
Original Assignee
Hollis Eden Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hollis Eden Pharmaceuticals Inc filed Critical Hollis Eden Pharmaceuticals Inc
Publication of AU1579700A publication Critical patent/AU1579700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
AU15797/00A 1998-12-15 1999-12-15 Cytokine combination therapy Abandoned AU1579700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11220698P 1998-12-15 1998-12-15
US60112206 1998-12-15
PCT/IB1999/002001 WO2000035472A2 (en) 1998-12-15 1999-12-15 Cytokine combination therapy

Publications (1)

Publication Number Publication Date
AU1579700A true AU1579700A (en) 2000-07-03

Family

ID=22342651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15797/00A Abandoned AU1579700A (en) 1998-12-15 1999-12-15 Cytokine combination therapy

Country Status (2)

Country Link
AU (1) AU1579700A (en)
WO (1) WO2000035472A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589184B2 (en) 2004-05-24 2009-09-15 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
US7553932B1 (en) 2005-04-25 2009-06-30 La Jolla Institute For Allergy And Immunology Methods of treating viral infection with IL-10 receptor antagonists
US8283165B2 (en) 2008-09-12 2012-10-09 Genvault Corporation Matrices and media for storage and stabilization of biomolecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
AU5297299A (en) * 1998-08-17 2000-03-06 Patrick T. Prendergast Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use

Also Published As

Publication number Publication date
WO2000035472A2 (en) 2000-06-22
WO2000035472A3 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
AU4943200A (en) Modified cytokine
EG24678A (en) Combination therapy
AUPO203996A0 (en) Therapeutic uses
AU5578599A (en) Chair
AU6873398A (en) Table construction
AU1101699A (en) Therapeutic pillow
GB9804885D0 (en) Therapeutic combination
IL127306A0 (en) Combination therapy
AU5970699A (en) Use
AU6827898A (en) Detergent-package combination
GB9816556D0 (en) Therapy
AU1710600A (en) Enhanced radiation therapy
AU5450399A (en) Pestivirus vaccination
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4443599A (en) Therapeutic bed
AU7761498A (en) Algicides
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU1579700A (en) Cytokine combination therapy
AU2227999A (en) Human ependymin
AU8155898A (en) Human preprotachykinin b
EP0904287A3 (en) Cytokine designated lerk-8
AU7641098A (en) Therapeutic composition
AU2202100A (en) Human brainiac-5
AU7583998A (en) Human chemokine zchemo-8
AU6782298A (en) Fibrocyte-based cellular therapy formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase